This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc). Active years: 2013-2019.
Company Filing History:
Years Active: 2013-2019
Title: Innovations by Jan Kessler in Cancer Treatment
Introduction
Jan Kessler is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of three patents to his name, Kessler's work focuses on the development of immunogenic compositions that can aid in the treatment and prevention of cancer.
Latest Patents
Kessler's latest patents include the invention of PRAME derived peptides and immunogenic compositions comprising these. The invention relates to a peptide that has a length of no more than 100 amino acids and includes at least 19 contiguous amino acids from the amino acid sequence of the human PRAME protein. This peptide comprises at least one HLA class II epitope and at least one HLA class I epitope from the amino acid sequence of the human PRAME protein. The use of this peptide, either as such or in a composition as a medicament, is aimed at the treatment and/or prevention of cancer.
Career Highlights
Jan Kessler is affiliated with Academisch Ziekenhuis Leiden, also known as LUMC. His work at this prestigious institution has allowed him to focus on groundbreaking research in immunology and cancer treatment. Kessler's dedication to his field is evident in his innovative approach to developing new therapeutic options for patients.
Collaborations
Throughout his career, Kessler has collaborated with esteemed colleagues, including Marieke Griffioen and Jan Wouter Drijfhout. These collaborations have further enhanced his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Jan Kessler's contributions to the field of cancer treatment through his patented innovations highlight the importance of research and collaboration in developing effective medical solutions. His work continues to pave the way for advancements in immunotherapy and cancer prevention.